These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21420428)

  • 1. Cytoplasmic dynein in neurodegeneration.
    Eschbach J; Dupuis L
    Pharmacol Ther; 2011 Jun; 130(3):348-63. PubMed ID: 21420428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic dynein: a key player in neurodegenerative and neurodevelopmental diseases.
    Chen XJ; Xu H; Cooper HM; Liu Y
    Sci China Life Sci; 2014 Apr; 57(4):372-7. PubMed ID: 24664850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in cytoplasmic dynein and its regulators cause malformations of cortical development and neurodegenerative diseases.
    Lipka J; Kuijpers M; Jaworski J; Hoogenraad CC
    Biochem Soc Trans; 2013 Dec; 41(6):1605-12. PubMed ID: 24256262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism and regulation of cytoplasmic dynein.
    Cianfrocco MA; DeSantis ME; Leschziner AE; Reck-Peterson SL
    Annu Rev Cell Dev Biol; 2015; 31():83-108. PubMed ID: 26436706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegenerative mutation in cytoplasmic dynein alters its organization and dynein-dynactin and dynein-kinesin interactions.
    Deng W; Garrett C; Dombert B; Soura V; Banks G; Fisher EM; van der Brug MP; Hafezparast M
    J Biol Chem; 2010 Dec; 285(51):39922-34. PubMed ID: 20889981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human cytoplasmic dynein heavy chain 1 and 2: observation of dynein-2 motor activity in vitro.
    Ichikawa M; Watanabe Y; Murayama T; Toyoshima YY
    FEBS Lett; 2011 Aug; 585(15):2419-23. PubMed ID: 21723285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct functional roles of cytoplasmic dynein defined by the intermediate chain isoforms.
    Pfister KK
    Exp Cell Res; 2015 May; 334(1):54-60. PubMed ID: 25576383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neurons rely on motor proteins.
    Holzbaur EL
    Trends Cell Biol; 2004 May; 14(5):233-40. PubMed ID: 15130579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic dynein transport machinery and its many cargoes.
    Reck-Peterson SL; Redwine WB; Vale RD; Carter AP
    Nat Rev Mol Cell Biol; 2018 Jun; 19(6):382-398. PubMed ID: 29662141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease.
    Gunawardena S; Goldstein LS
    J Neurobiol; 2004 Feb; 58(2):258-71. PubMed ID: 14704957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynein: An ancient motor protein involved in multiple modes of transport.
    Vallee RB; Williams JC; Varma D; Barnhart LE
    J Neurobiol; 2004 Feb; 58(2):189-200. PubMed ID: 14704951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRMP-2 directly binds to cytoplasmic dynein and interferes with its activity.
    Arimura N; Hattori A; Kimura T; Nakamuta S; Funahashi Y; Hirotsune S; Furuta K; Urano T; Toyoshima YY; Kaibuchi K
    J Neurochem; 2009 Oct; 111(2):380-90. PubMed ID: 19659462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death.
    Gonatas NK; Stieber A; Gonatas JO
    J Neurol Sci; 2006 Jul; 246(1-2):21-30. PubMed ID: 16545397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal transport defects: a common theme in neurodegenerative diseases.
    Roy S; Zhang B; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2005 Jan; 109(1):5-13. PubMed ID: 15645263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation and Regulation of Cytoplasmic Dynein.
    Canty JT; Yildiz A
    Trends Biochem Sci; 2020 May; 45(5):440-453. PubMed ID: 32311337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of double-headed cytoplasmic dynein into single-headed species and its motile properties.
    Toba S; Toyoshima YY
    Cell Motil Cytoskeleton; 2004 Aug; 58(4):281-9. PubMed ID: 15236358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoinhibition and cooperative activation mechanisms of cytoplasmic dynein.
    Torisawa T; Ichikawa M; Furuta A; Saito K; Oiwa K; Kojima H; Toyoshima YY; Furuta K
    Nat Cell Biol; 2014 Nov; 16(11):1118-24. PubMed ID: 25266423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective motor activation in organelle transport along axons.
    Cason SE; Holzbaur ELF
    Nat Rev Mol Cell Biol; 2022 Nov; 23(11):699-714. PubMed ID: 35637414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.